Variants in the Dihydropyrimidine Dehydrogenase, Methylenetetrahydrofolate Reductase and Thymidylate Synthase Genes Predict Early Toxicity of 5-Fluorouracil in Colorectal Cancer Patients

By Kristensen MH   Pedersen PL   Melsen GV   Ellehauge J   Mejer J  

The Journal of International Medical Research, Vol. 38, Iss. 3, 2010-06 ,pp. : 870-883

Field House Publishing

Access to resources Recommend Favorite

Implications of dihydropyrimidine dehydrogenase on 5-fluorouracil pharmacogenetics and pharmacogenomics

By Mattison Lori K   Soong Richie   Diasio Robert B  

Pharmacogenomics, Vol. 3, Iss. 4, 2002-07 ,pp. : 485-492

Future Medicine

Access to resources Recommend Favorite

Dihydropyrimidine Dehydrogenase Genotyping and Phenotyping for 5- Fluorouracil Dysmetabolism: Moving Towards Personalized Chemotherapy in Patients with Cancer

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 7, Iss. 4, 2009-12 ,pp. : 275-283

Bentham Science Publishers

Access to resources Recommend Favorite

Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity

By Amstutz Ursula   Froehlich Tanja K   Largiadèr Carlo R  

Pharmacogenomics, Vol. 12, Iss. 9, 2011-09 ,pp. : 1321-1336

Future Medicine

Access to resources Recommend Favorite

Dihydropyrimidine dehydrogenase gene variation and severe 5-fluorouracil toxicity: a haplotype assessment

By Amstutz Ursula   Farese Simone   Aebi Stefan   Largiadèèr Carlo R  

Pharmacogenomics, Vol. 10, Iss. 6, 2009-06 ,pp. : 931-944

Future Medicine

Access to resources Recommend Favorite